LATENT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH MINIMUM HEPATIC FIBROSIS
Study objective. To evaluate effect of peroral administration of L-ornitin-L-aspartate (LOLA) on the frequency of road traffic accidents in persons with hepatic disease at the pre-cirrhotic stage. Material and methods. The study included 42 patients – men aged 25-45, drivers with the driving experie...
Main Authors: | P. O. BOGOMOLOV, A. O. BUEVEROV, O. V. UVAROVA, M. V. MATSIEVICH |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2016-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1421 |
Similar Items
-
Possibilities of therapeutic correction of hyperammonemia and minimal hepatic encephalopathy in patients with chronic hepatitis C at the pre-cirrhotic stage
by: A O Buyeverov, et al.
Published: (2019-02-01) -
Hepatic encephalopathy: features of pharmacotherapy
by: A. V. Polukhina, et al.
Published: (2018-04-01) -
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy
by: Claudia Isabel Blanco Vela, et al.
Published: (2011-01-01) -
Modern view on hepatic encephalopathy: basic terms and concepts of pathogenesis
by: T. V. Shulyatnikova, et al.
Published: (2017-12-01) -
Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: A randomized controlled trial
by: Kapil Sharma, et al.
Published: (2014-01-01)